Furthermore, rescue experiments supported overexpression of miR-124 suppressed proliferation rates and increased Taxol sensitivity of breast cancer cells through targeting MCT1, indicating miR-124 may serve as an ideal therapeutic target against chemoresistant breast cancer. This evidence concerns the gene SLC16A1 and breast carcinoma.